Harrow’s IHEEZO (chloroprocaine HCl ophthalmic gel) 3% is a topical ocular anesthetic with a proven safety profile and reliable efficacy, and its simple administration with a sterile, single-use unit means your procedures are as efficient as possible. No need for multiple drugs and application methods. In a Phase III clinical trial of IHEEZO, 1 dose was shown to achieve sufficient ocular surface anesthesia in less than 90 seconds, lasting an average of 21.5 minutes—potentially making IHEEZO an ideal local anesthetic for patients undergoing routine ocular procedures. A permanent J-code facilitates reimbursement.
For more information, visit IHEEZO.com or click on "Learn More" below.
ILEVRO (nepafenac ophthalmic suspension) 0.3% from Harrow strikes at inflammation and pain after cataract surgery.
Learn More
The Surgeon’s Choice Card and Surgeon’s Choice Cannula Card from OASIS are alternatives to standard surgical preference cards that allow surgical teams to reduce prep time before surgery, reduce waste, and support a continuous flow from surgery to surgery.
Learn More
Tat Markers from Viscot Medical are temporary, tattoo-style site markers that cannot be moved or altered once placed, making them Joint Commission compliant.
Learn More
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when a printer took a galley.
Learn More
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when a printer took a galley.
Learn More
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when a printer took a galley.
Learn More